QUININE-BASED DRUGS FOR NOCTURNAL LEG MUSCLE CRAMPS CANNOT BE SOLD
This article was originally published in The Tan Sheet
Executive Summary
QUININE-BASED DRUGS FOR NOCTURNAL LEG MUSCLE CRAMPS CANNOT BE SOLD after February 1995 under FDA's OTC nocturnal leg muscle cramps final rule, which is expected to be published during the week of Aug. 22. FDA concluded that "new information has raised serious safety concerns over the OTC availability of quinine sulfate for this use." Quinine was classified in Category III (data insufficient to permit classification) in the November 1985 tentative final monograph for OTC nocturnal leg muscle cramp drugs.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning